81 related articles for article (PubMed ID: 7600545)
1. The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor alpha expression as a marker for the stage of progression.
Dragan Y; Teeguarden J; Campbell H; Hsia S; Pitot H
Cancer Lett; 1995 Jun; 93(1):73-83. PubMed ID: 7600545
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
Steinmetz KL; Klaunig JE
Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
[TBL] [Abstract][Full Text] [Related]
3. Comparison of experimental and theoretical parameters of the Moolgavkar-Venzon-Knudson incidence function for the stages of initiation and promotion in rat hepatocarcinogenesis.
Dragan YP; Hully J; Baker K; Crow R; Mass MJ; Pitot HC
Toxicology; 1995 Sep; 102(1-2):161-75. PubMed ID: 7482551
[TBL] [Abstract][Full Text] [Related]
4. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat.
Sargent L; Dragan Y; Xu YH; Sattler G; Wiley J; Pitot HC
Cancer Res; 1996 Jul; 56(13):2985-91. PubMed ID: 8674052
[TBL] [Abstract][Full Text] [Related]
5. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
6. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
7. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
8. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
[TBL] [Abstract][Full Text] [Related]
9. Cellular distributions of molecules with altered expression specific to the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
Takahashi M; Shibutani M; Woo GH; Inoue K; Fujimoto H; Igarashi K; Kanno J; Hirose M; Nishikawa A
Carcinogenesis; 2008 Nov; 29(11):2218-26. PubMed ID: 18586688
[TBL] [Abstract][Full Text] [Related]
10. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
DiGiovanni J; Rho O; Xian W; Beltràn L
Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
[TBL] [Abstract][Full Text] [Related]
11. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W
Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286
[TBL] [Abstract][Full Text] [Related]
12. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
Paik SY; Park YN; Kim H; Park C
Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-alpha expression is altered during experimental hepatocarcinogenesis.
Burr AW; Toole K; Mathew J; Hines JE; Chapman C; Burt AD
J Pathol; 1996 Jul; 179(3):276-82. PubMed ID: 8774483
[TBL] [Abstract][Full Text] [Related]
14. Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats.
Mukherjee B; Das T; Ghosh S; Datta S
Eur J Cancer Prev; 2007 Aug; 16(4):363-71. PubMed ID: 17554210
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-alpha expression in rat experimental hepatocarcinogenesis.
Pérez-Tomás R; Mayol X; Culleré X; Díaz Ruiz C; Domingo J
Histol Histopathol; 1992 Jul; 7(3):457-62. PubMed ID: 1504466
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of multistage carcinogenesis in rat liver.
Pitot HC; Dragan YP; Teeguarden J; Hsia S; Campbell H
Toxicol Pathol; 1996; 24(1):119-28. PubMed ID: 8839289
[TBL] [Abstract][Full Text] [Related]
18. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
19. Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis.
Drucker C; Parzefall W; Teufelhofer O; Grusch M; Ellinger A; Schulte-Hermann R; Grasl-Kraupp B
Carcinogenesis; 2006 Jan; 27(1):152-61. PubMed ID: 16081514
[TBL] [Abstract][Full Text] [Related]
20. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression.
Chakraborty T; Chatterjee A; Rana A; Srivastawa S; Damodaran S; Chatterjee M
Life Sci; 2007 Jul; 81(6):489-99. PubMed ID: 17651763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
